AQR Capital Management LLC Sells 51,443 Shares of Solventum Co. (NYSE:SOLV)

AQR Capital Management LLC lowered its position in Solventum Co. (NYSE:SOLV - Free Report) by 3.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,426,960 shares of the company's stock after selling 51,443 shares during the period. AQR Capital Management LLC owned about 0.83% of Solventum worth $94,265,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the company. Modus Advisors LLC purchased a new position in shares of Solventum during the 4th quarter valued at $25,000. Stonebridge Financial Group LLC bought a new position in shares of Solventum in the 4th quarter worth approximately $26,000. Crews Bank & Trust bought a new position in Solventum during the 4th quarter valued at approximately $32,000. Synergy Asset Management LLC bought a new position in Solventum during the 4th quarter valued at about $35,000. Finally, Spire Wealth Management purchased a new position in Solventum in the fourth quarter worth about $37,000.

Analysts Set New Price Targets

SOLV has been the subject of a number of research reports. Piper Sandler dropped their target price on shares of Solventum from $84.00 to $80.00 and set a "neutral" rating for the company in a research report on Wednesday, April 30th. Wells Fargo & Company raised their price objective on Solventum from $73.00 to $75.00 and gave the company an "equal weight" rating in a research note on Friday, February 28th. Bank of America boosted their target price on shares of Solventum from $80.00 to $85.00 and gave the company a "neutral" rating in a research note on Wednesday, February 26th. The Goldman Sachs Group lifted their price objective on shares of Solventum from $63.00 to $71.00 and gave the company a "sell" rating in a report on Monday, March 3rd. Finally, Morgan Stanley raised their target price on shares of Solventum from $73.00 to $80.00 and gave the stock an "equal weight" rating in a research report on Wednesday, March 5th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, Solventum has an average rating of "Hold" and a consensus target price of $79.29.

Solventum Price Performance

Solventum stock traded down $0.90 during midday trading on Tuesday, hitting $65.99. The company's stock had a trading volume of 140,641 shares, compared to its average volume of 1,276,750. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. Solventum Co. has a 12 month low of $47.16 and a 12 month high of $85.92. The company has a market capitalization of $11.42 billion and a PE ratio of 24.00. The stock's 50-day moving average price is $71.25 and its 200-day moving average price is $71.42.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.